Fotagliptin
A pharmaceutical drug used in the treatment of type 2 diabetes
Fotagliptin is a pharmaceutical drug that belongs to the class of medications known as DPP-4 inhibitors. It is primarily used in the management of type 2 diabetes mellitus, a chronic condition characterized by high blood sugar levels due to insulin resistance and relative insulin deficiency.
Mechanism of Action[edit | edit source]
Fotagliptin works by inhibiting the enzyme DPP-4, which is responsible for the degradation of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones play a crucial role in the regulation of glucose metabolism by enhancing insulin secretion from the pancreas in a glucose-dependent manner and suppressing glucagon release. By inhibiting DPP-4, fotagliptin increases the levels of active incretin hormones, thereby improving glycemic control in patients with type 2 diabetes.
Pharmacokinetics[edit | edit source]
Fotagliptin is administered orally and is absorbed into the bloodstream, where it exerts its effects on the DPP-4 enzyme. The pharmacokinetic profile of fotagliptin includes its absorption, distribution, metabolism, and excretion. It is metabolized primarily in the liver and excreted through the kidneys. The half-life of fotagliptin allows for once-daily dosing, which can improve patient adherence to the treatment regimen.
Clinical Use[edit | edit source]
Fotagliptin is indicated for the treatment of type 2 diabetes in adults. It can be used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin. The choice of combination therapy depends on the individual patient's needs, glycemic targets, and the presence of any contraindications or comorbidities.
Side Effects[edit | edit source]
Common side effects of fotagliptin include nasopharyngitis, headache, and upper respiratory tract infection. As with other DPP-4 inhibitors, there is a potential risk of pancreatitis, although this is rare. Patients should be monitored for signs and symptoms of pancreatitis, and the medication should be discontinued if pancreatitis is suspected.
Contraindications[edit | edit source]
Fotagliptin is contraindicated in patients with a known hypersensitivity to the drug or any of its components. It should be used with caution in patients with severe renal impairment or end-stage renal disease, as dose adjustments may be necessary.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD